OTCMKTS:CPMV Mosaic ImmunoEngineering Q2 2025 Earnings Results & Report $0.33 +0.27 (+432.80%) As of 10/9/2026 12:56 PM Eastern Mosaic ImmunoEngineering reported Q2 2025 earnings on August 19, 2025. The company reported EPS of -$0.02. Research:ProfileEarnings History Earnings Announcement Details QuarterQ2 2025Report DateAugust 19, 2025TimeAfter Market Closes Mosaic ImmunoEngineering EPS ResultsActual EPS-$0.02Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AMosaic ImmunoEngineering Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Mosaic ImmunoEngineering Q2 2025 Earnings FAQ Did Mosaic ImmunoEngineering beat earnings estimates for Q2 2025? Mosaic ImmunoEngineering (OTCMKTS:CPMV) reported earnings of -$0.02 per share for Q2 2025. The report was announced on Tuesday, August 19, 2025. Mosaic ImmunoEngineering Earnings HeadlinesMosaic ImmunoEngineering Delays Annual 10-K FilingJuly 12, 2026 | theglobeandmail.comMosaic ImmunoEngineering, Inc. (CPMV) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 10 at 1:00 AM | Altimetry (Ad)Mosaic ImmunoEngineering, Inc. (CPMV)November 17, 2024 | finance.yahoo.comMosaic Co.November 5, 2024 | wsj.comMosaic ImmunoEngineering (OTC:CPMV) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comSee More Mosaic ImmunoEngineering Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Mosaic ImmunoEngineering? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mosaic ImmunoEngineering and other key companies, straight to your email. Email Address About Mosaic ImmunoEngineeringMosaic ImmunoEngineering (OTCMKTS:CPMV), Inc. is a biotechnology company focused on developing immunotherapies designed to stimulate the immune system to recognize and attack disease-related cells. Its work has centered primarily on therapeutic approaches for cancer and potentially other serious diseases. The company’s activities have included research into multi-antigen immune-response technologies and vaccine-based therapies intended to activate T cells against selected targets. Publicly available information about its current development programs, commercial products, geographic operations and leadership is limited.View Mosaic ImmunoEngineering ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
